George K Ng

CIK 1638744 · Chief Executive Officer · last filed 2026-07-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$57.9K

Companies

3

Total Filings

29

Lifetime Open-Market Net

$973.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PCSA Chief Executive Officer 18,980 $3.05 $57.9K $140.7K 17 2026-07-01
HURA Director $2.13 $0 3 2026-02-17
Sorrento Therapeutics, Inc. (SRNE) Delisted See Remarks 403,599 $0.00 $202 $833.2K 9 2018-02-28

Recent Filings · Page 3 of 3

29 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-02-28 Sorrento Therapeutics, Inc. (SRNE) Delisted Mixed +253,469 $895.5K EDGAR
2017-09-15 Sorrento Therapeutics, Inc. (SRNE) Delisted Other (J) +89,339 $0 EDGAR
2017-09-15 Sorrento Therapeutics, Inc. (SRNE) Delisted Grant (A) $0 EDGAR
2017-02-03 Sorrento Therapeutics, Inc. (SRNE) Delisted Sell (S) −40,000 -$206.0K EDGAR
2016-11-09 Sorrento Therapeutics, Inc. (SRNE) Delisted Grant (A) +89,338 $0 EDGAR
2016-08-16 Sorrento Therapeutics, Inc. (SRNE) Delisted Grant (A) $0 EDGAR
2016-03-15 Sorrento Therapeutics, Inc. (SRNE) Delisted Grant (A) $0 EDGAR
2015-08-21 Sorrento Therapeutics, Inc. (SRNE) Delisted Buy (P) +888 $12.0K EDGAR
2015-08-05 Sorrento Therapeutics, Inc. (SRNE) Delisted Buy (P) +11,453 $131.7K EDGAR
Showing 2129 of 29
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.